Article
Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
Journal of molecular endocrinology - 1 Apr 2008
Plourde Marie, Manhes Caroline, Leblanc Gilles, Durocher Francine, Dumont Martine, Sinilnikova Olga, Simard Jacques
Abstract excerpt
Estrogen exposure is a risk factor for breast cancer. Given that HSD17B2 gene encodes an enzyme that catalyses estradiol inactivation, it appears as a good candidate breast cancer susceptibility gene. This study was designed to screen for HSD17B2 germline mutations potentially involved in breast cancer predisposition. Our re-sequencing analysis did not identify any deleterious germline mutations, and therefore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
